<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02419352</url>
  </required_header>
  <id_info>
    <org_study_id>331/21-9-10</org_study_id>
    <nct_id>NCT02419352</nct_id>
  </id_info>
  <brief_title>Sugammadex and Cognitive Function</brief_title>
  <official_title>Effect of Sugammadex Versus Neostigmine/Atropine Combination on Cognitive Function After Elective Adult Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Attikon Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Attikon Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post operative cognitive dysfunction (POCD) is recognized as a frequent complication after
      both cardiac and non cardiac surgery, affecting approximately 1/3 of the patients. The aim of
      this study is to examine the possible effect of the novel reversal agent sugammadex versus
      neostigmine/ atropine combination on cognitive function of adult patients after elective
      surgery during the early post operative period as well as at discharge.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Mini-Mental State Evaluation test</measure>
    <time_frame>Preoperatively, 1 hour postoperatively, at discharge (1-15 days postoperatively)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the clock-drawing test</measure>
    <time_frame>Preoperatively, 1 hour postoperatively, at discharge (1-15 days postoperatively)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the Isaacs set test</measure>
    <time_frame>Preoperatively, 1 hour postoperatively, at discharge (1-15 days postoperatively)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time from reversal agent administration to extubation</measure>
    <time_frame>After reversal agent administration</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Post Operative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Sugammadex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sugammadex is administered to reverse rocuronium-induced neuromuscular blockade at the end of elective surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neostigmine/atropine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Neostigmine combined to atropine is administered to reverse rocuronium-induced neuromuscular blockade at the end of elective surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex</intervention_name>
    <arm_group_label>Sugammadex</arm_group_label>
    <other_name>Bridion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neostigmine/atropine</intervention_name>
    <arm_group_label>Neostigmine/atropine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged &gt;40 years old

          -  ASA I-III

          -  Patients scheduled for elective surgery with general anaesthesia.

        Exclusion Criteria:

          -  Neuro-, vascular-, orthopedic- or cardiac surgery

          -  Known psychiatric or disease of the CNS

          -  History of craniotomy

          -  Receiving tranquillisers or antidepressants on a regular basis pre-operatively

          -  Alcoholism or drug dependence

          -  History of stroke

          -  Refusal of patient

          -  Inability to read or write

          -  MMSE &lt; 22 pre-operatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str.</name>
      <address>
        <city>Athens</city>
        <zip>12462</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2015</study_first_submitted>
  <study_first_submitted_qc>April 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2015</study_first_posted>
  <last_update_submitted>December 28, 2015</last_update_submitted>
  <last_update_submitted_qc>December 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Attikon Hospital</investigator_affiliation>
    <investigator_full_name>Chrysanthi Batistaki</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology, 2nd Department of Anesthesiology, School of Medicine, University of Athens</investigator_title>
  </responsible_party>
  <keyword>Cognitive function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

